Abzena
San Diego, CA / Bristol, PA / Cambridge, UK
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmAb, ADC, AOC, RDC, Bispecifics, Fusion Proteins, Biosimilars
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
Abzena Announces Major Investment in Bioconjugation and ADC Capabilities in Response to Increasing Industry Demand - PR Newswire
Pfizer bolsters North Carolina manufacturing footprint with Abzena plant purchase - Fierce Pharma
Abzena Appoints Dr Moncef Slaoui to Board - citybiz
Abzena expands biologic manufacturing site - Cleanroom Technology
Abzena Recognized as a Market-Leading Antibody-Drug Conjugate CDMO in Frost & Sullivan Radar Report - Yahoo Finance
Abzena Recognized as a Market-Leading Antibody-Drug Conjugate CDMO in Frost & Sullivan Radar Report - Bolsamania
Abzena selects NC for $200m biologics plant - BioProcess International
CEO Spotlight: Matthew Stober - Contract Pharma
Abzena, Argonaut Form Drug Development Alliance - Pharmaceutical Commerce
Manufacturing roundup: Symbiosis, BioGrad, Abzena, Eschbach and more - European Pharmaceutical Review
Represent this organization? Contact us to verify or update this profile.